Edwards Lifesciences (EW) PT Raised to $145 at RBC Capital; Reinforced Confidence Following Management Meetings
Tweet Send to a Friend
RBC Capital raised its price target on Edwards Lifesciences (NYSE: EW) to $145.00 (from $140.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
